Protagenic Therapeutics, Inc.
PTIX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001022899
In the last 90 days, Protagenic Therapeutics, Inc. insiders filed 7 open-market purchases and 0 sales; 2 institutions reported holding it in 13F filings for Q2 2026, worth $25.4K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Protagenic Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 13 | 1 | 19 | +7 |
| Shares | 237.0K | 3 | 967.9K | +730.9K (+308.4%) |
| Value | $683.0K | $0 | $1.81M | +$1.13M (+164.9%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Oracle Investment Management Inc | 500,000 | $935.0K | 0.12% |
| Morgan Stanley | 58,063 | $109.0K | 0.00% |
| Citadel Advisors LLC | 38,712 | $72.0K | 0.00% |
| Renaissance Technologies LLC | 23,200 | $43.0K | 0.00% |
| First Republic Investment Management, Inc. | 10,500 | $20.0K | 0.00% |
| Advisor Group Holdings, Inc. | 5,055 | $9.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,733 | $3.00K | 0.00% |
| Fifth Third Bancorp | 1 | $0 | 0.00% |
Sold out (1)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Squarepoint Ops LLC | 19,718 | $57.0K |
Not filed for Q3 2021 yet (1)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 3 | $0 |